Skip to main content

Ana Alvarez Guaita

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Ana Alvarez Guaita

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Gloria Aparicio Español

Gloria Aparicio Español

Biomedical Research in Melanoma
Read more
Carla Soto Santoyo

Carla Soto Santoyo

Research technician
Kidney Physiopathology
Read more
Judith Martínez Lacambra

Judith Martínez Lacambra

Tècnic/a Superior Recerca
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
Alba Márquez Gallego

Alba Márquez Gallego

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.